Lessons from Nod2 studies: Towards a link between Crohn's disease and bacterial sensing

Trends in Immunology

Volumn 24, Issue 12, 2003, Pages 652-658

  Girardin, Stephen E ^a   Hugot, Jean Pierre ^b   Sansonetti, Philippe J ^a  

^a INSERM   (France)

^b FONDATION JEAN DAUSSET CEPH   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CASPASE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOKINE; GAMMA INTERFERON; NUCLEAR FACTOR; PROTEIN; PROTEOGLYCAN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; BACTERIUM; BLAU SYNDROME; CROHN DISEASE; ENZYME ACTIVATION; GENE CONTROL; GENETIC PREDISPOSITION; HUMAN; IMMUNITY; INFLAMMATORY DISEASE; MOLECULAR BIOLOGY; NONHUMAN; PATHOGENESIS; PROTEIN FAMILY; PROTEIN MOTIF; REVIEW; SENSOR; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0345303939     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2003.10.007     Document Type: Review

References (62)

1. Beutler B., Rietschel E.T. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 3:2003;169-176.
2. Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:2001;135-145.
3. Chamaillard M., et al. Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell. Micro. 5:2003;581-592.
4. Inohara N., Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3:2003;371-382.
5. Bertin J., et al. Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-κB. J. Biol. Chem. 274:1999;12955-12958.
6. Inohara N., et al. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-κB. J. Biol. Chem. 274:1999;14560-14567.
7. Hugot J.P., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 411:2001;599-603.
8. Ogura Y., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 411:2001;603-606.
9. Miceli-Richard C., et al. CARD15 mutations in Blau syndrome. Nat. Genet. 29:2001;19-20.
10. Hugot J.P., et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature. 379:1996;821-823.
11. Hampe J., et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am. J. Hum. Genet. 64:1999;808-816.
12. Hampe J., et al. Linkage of inflammatory bowel disease to human chromosome 6p. Am. J. Hum. Genet. 65:1999;1647-1655.
13. Satsangi J., et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat. Genet. 14:1996;199-202.
14. Rioux J.D., et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am. J. Hum. Genet. 66:2000;1863-1870.
15. Rioux J.D., et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat. Genet. 29:2001;223-228.
16. Duerr R.H., et al. High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am. J. Hum. Genet. 66:2000;1857-1862.
17. Cho J.H., et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc. Natl. Acad. Sci. U. S. A. 95:1998;7502-7507.
18. Hampe J., et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet. 357:2001;1925-1928.
19. Hampe J., et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet. 359:2002;1661-1665.
20. Ahmad T., et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology. 122:2002;854-866.
21. Cuthbert A.P., et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology. 122:2002;867-874.
22. Vermeire S., et al. CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am. J. Hum. Genet. 71:2002;74-83.
23. Murillo L., et al. CARD15 gene and the classification of Crohn's disease. Immunogenetics. 54:2002;59-61.
24. Bairead E., et al. Association of NOD2 with Crohn's Disease in a homogenous Irish population. Eur. J. Hum. Genet. 11:2003;237-244.
25. Linde K., et al. Card15 and Crohn's disease: healthy homozygous carriers of the 3020insC frameshift mutation. Am. J. Gastroenterol. 98:2003;613-617.
26. Helio T., et al. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut. 52:2003;558-562.
27. Louis E., et al. Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut. 52:2003;552-557.
28. Cavanaugh J.A., et al. CARD15/NOD2 risk alleles in the development of Crohn's disease in the Australian population. Ann. Hum. Genet. 67:2003;35-41.
29. Lesage S., et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am. J. Hum. Genet. 70:2002;845-857.
30. Inoue N., et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology. 123:2002;86-91.
31. Yamazaki K., et al. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J. Hum. Genet. 47:2002;469-472.
32. Bonen D.K., et al. Racial differences in Nod2 variation: characterisation of Nod2 in African-Ameriacans with Crohn Disease. Gastroenterology. 122:2002;A29.
33. Abreu M.T., et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology. 123:2002;679-688.
34. Radlmayr M., et al. The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology. 122:2002;2091-2092.
35. Vermeire S., et al. NOD2/CARD15 does not influence response to infliximab in Crohn's disease. Gastroenterology. 123:2002;106-111.
36. Mascheretti S., et al. Response to infliximab treatment in Crohn's disease is not associated with mutations in the CARD15 (NOD2) gene: an analysis in 534 patients from two multicenter, prospective GCP-level trials. Pharmacogenetics. 12:2002;509-515.
37. Chamaillard M., et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc. Natl. Acad. Sci. U. S. A. 100:2003;3455-3460.
38. Girardin S.E., et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278:2003;8869-8872.
39. Inohara N., et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278:2003;5509-5512.
40. Inohara N., et al. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J. Biol. Chem. 276:2001;2551-2554.
41. Girardin S.E., et al. CARD4/Nod1 mediates NF-κB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2:2001;736-742.
42. Girardin S.E., et al. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science. 300:2003;1584-1587.
43. Chamaillard M., et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4:2003;702-707.
44. Navarre W.W., Schneewind O. Surface proteins of Gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol. Mol. Biol. Rev. 63:1999;174-229.
45. Girardin, S.E., et al. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J. Biol. Chem. (in press).
46. Inohara N., et al. An induced proximity model for NF-κB activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275:2000;27823- 27831.
47. Stehlik C., et al. CARD6 is a modulator of NF-κB activation by Nod1- and Cardiak-mediated pathways. J. Biol. Chem. 278:2003;31941-31949.
48. Ogura Y., et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J. Biol. Chem. 276:2001;4812-4818.
49. Yoo N.J., et al. Nod1, a CARD protein, enhances pro-interleukin-1β processing through the interaction with pro-caspase-1. Biochem. Biophys. Res. Commun. 299:2002;652-658.
50. Rosenstiel P., et al. TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology. 124:2003;1001-1009.
51. Gutierrez O., et al. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-κB activation. J. Biol. Chem. 277:2002;41701-41705.
52. Hisamatsu T., et al. IFN-γ augments CARD4/NOD1 gene and protein expression through IRF-1 in intestinal epithelial cells. J. Biol. Chem. 17:2003;17.
53. Berrebi D., et al. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut. 52:2003;840-846.
54. Hisamatsu T., et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology. 124:2003;993-1000.
55. Zouali H., et al. CARD4/NOD1 is not involved in inflammatory bowel disease. Gut. 52:2003;71-74.
56. Philpott D.J., et al. Innate immune responses of epithelial cells following infection with bacterial pathogens. Curr. Opin. Immunol. 13:2001;410-416.
57. Ellingsen E., et al. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14. Med. Sci. Monit. 8:2002;BR149-BR156.
58. Schroder N.W., et al. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278:2003;15587-15594.
59. Morath S., et al. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J. Exp. Med. 195:2002;1635-1640.
60. Luker K.E., et al. Tracheal cytotoxin structural requirements for respiratory epithelial damage in Pertussis. Mol. Microbiol. 16:1995;733-743.
61. Heiss L.N., et al. Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of Pertussis. Proc. Natl. Acad. Sci. U. S. A. 91:1994;267-270.
62. Cundell D.R., et al. Effect of tracheal cytotoxin from Bordetella pertussis on human neutrophil function in vitro. Infect. Immun. 62:1994;639-643.